Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2009
01/07/2009CN100448874C N-aroyl cyclic amines
01/07/2009CN100448870C 2-aminoquinoline derivative
01/07/2009CN100448868C Tri-substituted heteroaryls and methods of making and using the same
01/07/2009CN100448687C Imaging system
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/06/2009US7473701 Substituted indazoles, compositions containing them, method of production and use
01/06/2009US7473695 4-imidazolin-2-one compounds
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
01/06/2009US7473686 Thrombopoietin mimetics
01/06/2009CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
01/06/2009CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors
01/06/2009CA2421008C Substituted heterocyclic compounds for treating multidrug resistance
01/06/2009CA2369504C Pyrazole compositions useful as inhibitors of erk
01/06/2009CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
01/06/2009CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
01/02/2009DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
01/01/2009US20090005580 Compounds, compositions and methods
01/01/2009US20090005431 Substituted pyrrolidines
01/01/2009US20090005391 Tricyclo Substituted Amides
12/2008
12/31/2008WO2009002469A1 Phthalazine compounds, compositions and methods of use
12/31/2008WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists
12/31/2008WO2009001949A1 Pyrazolone derivative
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001730A1 Novel compound having β secretase inhibitory activity
12/31/2008WO2009001369A1 An improved process for the preparation of alfuzosin hydrochloride
12/31/2008WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors
12/31/2008WO2009000878A1 Kallikrein 7 modulators
12/31/2008WO2009000757A1 Piperazine compounds with herbicidal action
12/31/2008WO2008135181A3 Insecticidal substituted 2-aminoindanes
12/31/2008WO2008082487A3 Novel jnk inhibitors
12/31/2008EP2009006A1 Ureide derivative and use thereof for medical purposes
12/31/2008EP2007789A2 Hcv/hiv inhibitors and their uses
12/31/2008EP2007756A2 Modulators of atp-binding cassette transporters
12/31/2008EP2007755A2 Fused ring thrombin receptor antagonists
12/31/2008EP2007751A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
12/31/2008EP2007749A2 Tetralines antagonists of the h-3 receptor
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007734A1 Enzyme inhibitors
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007725A2 Non-peptidic renin inhibitors nitroderivatives
12/31/2008EP2007716A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
12/31/2008EP1765809B1 Xanthine derivatives useful as muscarinic receptor antagonists
12/31/2008EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
12/31/2008EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/31/2008EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors
12/31/2008EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
12/31/2008EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound
12/31/2008CN101336240A Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
12/31/2008CA2691932A1 Use of compounds for preparing anti-tuberculosis agents
12/31/2008CA2691849A1 Kallikrein 7 modulators
12/31/2008CA2691772A1 Crystalline polymorph of exemestane
12/31/2008CA2690378A1 Phthalazine compounds, compositions and methods of use
12/31/2008CA2690335A1 Benzazepine derivatives useful as vasopressin antagonists
12/31/2008CA2690145A1 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
12/31/2008CA2686224A1 Piperazine compounds having herbicidal action
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470798 7,8-bicycloalkyl-chroman derivatives
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470711 Piperidinyl substituted cyclohexane-1,4-diamines
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470709 Benzimidazole quinolinones and uses thereof
12/30/2008US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/30/2008US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent
12/30/2008US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis
12/30/2008US7470681 Pyrimidine compounds
12/30/2008CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis
12/30/2008CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/30/2008CA2226256C New thrombin inhibitors, their preparation and use
12/25/2008US20080319210 Method for purifying dianhydrides
12/25/2008US20080319198 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
12/25/2008US20080319022 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
12/25/2008US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta
12/25/2008US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
12/25/2008US20080319011 Protein tyrosine kinase enzyme inhibitors
12/25/2008US20080319003 Cyclic amine compound and pest control agent
12/25/2008US20080318967 Hair Growth Promoting Agents
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318903 Methods for treating cancer
12/25/2008US20080318902 Triheterocyclic compounds and compositions thereof
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/24/2008WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease
12/24/2008WO2008157404A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156208A1 5-phenyl-3-pyridazinone derivative
12/24/2008WO2008156105A1 Organic electroluminescence element material, organic electroluminescence element, display device and illuminating device
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008WO2008155022A1 Pyrrole derivatives as p2y12 antagonists
12/24/2008WO2008121861A3 Pyrazole and pyrrole compounds useful in treating iron disorders
12/24/2008WO2008107481A8 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
12/24/2008WO2008104597A3 Sulfonyltryptophanols